David K Chang (David Chang)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Neuroendocrine Tumors

Transforming Growth Factor

Long Noncoding Rna

Top Venues

Journal of clinical medicine

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tingting Zhao, Lihua Cao, Xue-Jun Gan, David K Chang, Jianmin Wu
ReProMSig: an integrative platform for development and application of reproducible multivariable models for cancer prognosis supporting guideline-based transparent reporting. Briefings in bioinformatics (2023)
Adam S Bryce, Stephan B Dreyer, Fieke E M Froeling, David K Chang
Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Cancers 14 (21) (2022)
Meera Patel, Kathryn A F Pennel, Jean A Quinn, Hannah Hood, David K Chang, Andrew V Biankin, Selma Rebus, Antonia K Roseweir, James Hugh Park, Paul G Horgan, Donald C McMillan, Joanne Edwards
Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer. British journal of cancer 126 (12) (2022)
Raffaella Casolino, Salvatore Paiella, Danila Azzolina, Philip A Beer, Vincenzo Corbo, Giulia Lorenzoni, Dario Gregori, Talia Golan, Chiara Braconi, Fieke E M Froeling, Michele Milella, Aldo Scarpa, Antonio Pea, Giuseppe Malleo, Roberto Salvia, Claudio Bassi, David K Chang, Andrew V Biankin
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Fieke E M Froeling, Raffaella Casolino, Antonio Pea, Andrew V Biankin, David K Chang
Molecular Subtyping and Precision Medicine for Pancreatic Cancer. Journal of clinical medicine 10 (1) (2021)
Vanessa Lakis, Rita T Lawlor, Felicity Newell, Ann-Marie Patch, Andrea Mafficini, Anguraj Sadanandam, Lambros T Koufariotis, Rebecca L Johnston, Conrad Leonard, Scott Wood, Borislav Rusev, Vincenzo Corbo, Claudio Luchini, Sara Cingarlini, Luca Landoni, Roberto Salvia, Michele Milella, David K Chang, Peter Bailey, Nigel B Jamieson, Fraser Duthie, Marie-Claude Gingras, Donna M Muzny, David A Wheeler, Richard A Gibbs, Massimo Milione, null null, null null, Paolo Pederzoli, Jaswinder S Samra, Anthony J Gill, Amber L Johns, John V Pearson, Andrew V Biankin, Sean M Grimmond, Nicola Waddell, Katia Nones, Aldo Scarpa
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications biology 4 (1) (2021)
Raphaela Schwappacher, Walburga Dieterich, Dejan Reljic, Christian Pilarsky, Debabrata Mukhopadhyay, David K Chang, Andrew V Biankin, Jürgen Siebler, Hans Joachim Herrmann, Markus F Neurath, Yurdagül Zopf
Muscle-Derived Cytokines Reduce Growth, Viability and Migratory Activity of Pancreatic Cancer Cells. Cancers 13 (15) (2021)
Sneha Vivekanandhan, Vijay Sagar Madamsetty, Ramcharan Singh Angom, Shamit Kumar Dutta, Enfeng Wang, Thomas R Caulfield, Alexandre A Pletnev, Rosanna Upstill-Goddard, Yan W Asmann, David K Chang, Mark R Spaller, Debabrata Mukhopadhyay
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS. Cancers 13 (16) (2021)
Pietro Carotenuto, Francesco Amato, Andrea Lampis, Colin Rae, Somaieh Hedayat, Maria C Previdi, Domenico Zito, Maya Raj, Vincenza Guzzardo, Francesco Sclafani, Andrea Lanese, Claudia Parisi, Caterina Vicentini, Ian Said-Huntingford, Jens C Hahne, Albert Hallsworth, Vladimir Kirkin, Kate Young, Ruwaida Begum, Andrew Wotherspoon, Kyriakos Kouvelakis, Sergio Xavier Azevedo, Vasiliki Michalarea, Rosanna Upstill-Goddard, Sheela Rao, David Watkins, Naureen Starling, Anguraj Sadanandam, David K Chang, Andrew V Biankin, Nigel B Jamieson, Aldo Scarpa, David Cunningham, Ian Chau, Paul Workman, Angelo Paolo Dei Tos, Nicola Valeri, Chiara Braconi
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Nature communications 12 (1) (2021)